For the EQAPOL Program, EQA or Proficiency Testing (PT) programs are conducted for the following assays:
- ELISpot
- Luminex
- Flow Cytometry
- Limiting Antigen Avidity (LAg) Incidence Assay
- SARS-CoV-2 Antibody Assay
Participation in an EQAPOL PT program is at the discretion of DAIDS and is generally reserved for laboratories performing the aforementioned assays for DAIDS-sponsored clinical trial studies. There is no cost to participate in the EQAPOL EQA programs. To inquire whether your laboratory is eligible to participate in one of the EQAPOL EQA programs, please use the "Contact Us" page or send an email to EQAPOL.